Cite

HARVARD Citation

    Shaw, C. et al. (n.d.). Safety and immunogenicity of a mRNA-based chikungunya vaccine in a phase 1 dose-ranging trial. International journal of infectious diseases. pp. 17-. [Online]. 
  
Back to record